Patients with Metastatic Melanoma Receiving Anticancer Drugs: Changes in Overall Survival, 2010

Patients with Metastatic Melanoma Receiving Anticancer Drugs: Changes in Overall Survival, 2010–2017

Published:2021-04 Issue:4 Volume:141 Page:830-839.e3
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Poizeau Florence^ORCID,Kerbrat Sandrine^ORCID,Happe André^ORCID,Rault Caroline^ORCID,Drezen Erwan^ORCID,Balusson Frédéric^ORCID,Tuppin Philippe^ORCID,Guillot Bernard^ORCID,Thuret Anne^ORCID,Boussemart Lise^ORCID,Dinulescu Monica^ORCID,Pracht Marc^ORCID,Lesimple Thierry^ORCID,Droitcourt Catherine^ORCID,Oger Emmanuel^ORCID,Dupuy Alain^ORCID

Funder

Agence Nationale de Sécurité du Médicament et des Produits de Santé

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference44 articles.

1. Final version of 2009 AJCC melanoma staging and classification;Balch;J Clin Oncol,2009

2. The best use of the Charlson comorbidity index with electronic health care database to predict mortality;Bannay;Med Care,2016

3. The national healthcare system claims databases in France, SNIIRAM and EGB: powerful tools for pharmacoepidemiology;Bezin;Pharmacoepidemiol Drug Saf,2017

4. Efficacy and safety of nivolumab in metastatic melanoma: real-world practice;Bocquet-Tremoureux;Eur J Dermatol,2019

5. Real-world data: towards achieving the achievable in cancer care;Booth;Nat Rev Clin Oncol,2019

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metastasiertes Melanom: Neue Kombinationstherapien und Studienansätze;Trillium Krebsmedizin;2024-06-04

2. Melanoma epidemiology in Europe: what is new?;Italian Journal of Dermatology and Venereology;2024-04

3. Survival of patients with unfavorable prognosis cutaneous melanoma with increased use of immunotherapy agents: a population‐based study in Belgium;International Journal of Dermatology;2024-01-31

4. Sustained improved survival of patients with metastatic melanoma after the introduction of anti-PD-1-based therapies;European Journal of Cancer;2023-12

5. Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of Melanoma;Journal of Nanobiotechnology;2023-10-19